UK markets close in 3 hours 41 minutes

Dechra Pharmaceuticals plc (DPH.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
4,952.00+72.00 (+1.48%)
As of 12:34PM BST. Market open.
Currency in GBp

Valuation measures

Market cap (intra-day) 55.25B
Enterprise value 35.45B
Trailing P/E 95.08
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)8.68
Price/book (mrq)8.30
Enterprise value/revenue 38.97
Enterprise value/EBITDA 734.30

Trading information

Stock price history

Beta (5Y monthly) 0.49
52-week change 339.51%
S&P500 52-week change 330.30%
52-week high 35,525.00
52-week low 33,132.00
50-day moving average 34,935.25
200-day moving average 34,525.11

Share statistics

Avg vol (3-month) 3284.05k
Avg vol (10-day) 3256.18k
Shares outstanding 5108.29M
Implied shares outstanding 6N/A
Float 8107.73M
% held by insiders 11.58%
% held by institutions 174.67%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.41
Forward annual dividend yield 40.83%
Trailing annual dividend rate 30.41
Trailing annual dividend yield 30.01%
5-year average dividend yield 41.02
Payout ratio 468.80%
Dividend date 3N/A
Ex-dividend date 428 Oct 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Jun 2021
Most-recent quarter (mrq)30 Jun 2021

Profitability

Profit margin 9.13%
Operating margin (ttm)14.31%

Management effectiveness

Return on assets (ttm)4.44%
Return on equity (ttm)8.74%

Income statement

Revenue (ttm)608M
Revenue per share (ttm)5.62
Quarterly revenue growth (yoy)15.60%
Gross profit (ttm)345.9M
EBITDA 123M
Net income avi to common (ttm)55.5M
Diluted EPS (ttm)51.00
Quarterly earnings growth (yoy)55.60%

Balance sheet

Total cash (mrq)118.4M
Total cash per share (mrq)1.09
Total debt (mrq)318.6M
Total debt/equity (mrq)50.34
Current ratio (mrq)2.52
Book value per share (mrq)5.85

Cash flow statement

Operating cash flow (ttm)89.1M
Levered free cash flow (ttm)-23.82M